Literature DB >> 19879441

Corticosteroid treatment in chronic rhinosinusitis: the possibilities and the limits.

Joaquim Mullol1, Andrés Obando, Laura Pujols, Isam Alobid.   

Abstract

Chronic rhinosinusitis, including nasal polyps, is an inflammatory disease of the nose and sinuses. The medical treatment, mainly topical intranasal and oral corticosteroids, constitutes its first line of therapy. Long-term treatment with corticosteroid nasal spray reduces inflammation and nasal polyp size, and improves nasal symptoms such as nasal blockage, rhinorrea, and the loss of smell. Corticosteroid intranasal drops may be used when intranasal spray fails to demonstrate efficacy. Short courses of oral steroids are recommended in severe chronic rhinosinusitis with nasal polyps or when a rapid symptomatic improvement is needed. Endoscopic sinus surgery is only recommended when the medical treatment fails. Intranasal corticosteroids should be continued postoperatively. When using intranasal corticosteroids, care should be taken in selected populations such as children, pregnant women, and elderly patients; especially in those patients with comorbid conditions such as asthma, in which the overall steroid intake can be high due to the administration of both intranasal and inhaled corticosteroids.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19879441     DOI: 10.1016/j.iac.2009.07.001

Source DB:  PubMed          Journal:  Immunol Allergy Clin North Am        ISSN: 0889-8561            Impact factor:   3.479


  17 in total

1.  A Computational Study of Nasal Spray Deposition Pattern in Four Ethnic Groups.

Authors:  Jarrod A Keeler; Aniruddha Patki; Charles R Woodard; Dennis O Frank-Ito
Journal:  J Aerosol Med Pulm Drug Deliv       Date:  2015-08-13       Impact factor: 2.849

2.  Peripheral blood and tissue T regulatory cells in chronic rhinosinusitis.

Authors:  Shilpy Sharma; So Watanabe; Anita Sivam; JiangHong Wang; Samantha J Neuwirth; Rosanne I Perez; Marcella De Tineo; Fuad M Baroody; Robert M Naclerio; Jayant M Pinto
Journal:  Am J Rhinol Allergy       Date:  2012 Sep-Oct       Impact factor: 2.467

Review 3.  Biomarkers in the evaluation and management of chronic rhinosinusitis with nasal polyposis.

Authors:  Yao Yao; Shumin Xie; Chunguang Yang; Jianhui Zhang; Xuewen Wu; Hong Sun
Journal:  Eur Arch Otorhinolaryngol       Date:  2017-04-01       Impact factor: 2.503

4.  Structural organization and cellular localization of tuftelin-interacting protein 11 (TFIP11).

Authors:  X Wen; Y-P Lei; Y L Zhou; C T Okamoto; M L Snead; M L Paine
Journal:  Cell Mol Life Sci       Date:  2005-05       Impact factor: 9.261

5.  Efficacy and safety of delivery of topical medication on to the frontal sinus at different head positions after frontal sinusotomy.

Authors:  Yu-Xiao Wu; Min Wang; Hui Li; Zhi-Min Xing; Mu-Han Shi; Shi-En Huang; Yan Liu; Cong-Li Geng
Journal:  Eur Arch Otorhinolaryngol       Date:  2020-02-13       Impact factor: 2.503

Review 6.  Update on Intranasal Medications in Rhinosinusitis.

Authors:  Kornkiat Snidvongs; Sanguansak Thanaviratananich
Journal:  Curr Allergy Asthma Rep       Date:  2017-07       Impact factor: 4.806

7.  Evaluation of intraoperative bleeding during an endoscopic surgery of nasal polyposis after a pre-operative single dose versus a 5-day course of corticosteroid.

Authors:  Saeid Atighechi; Mohammad Reza Azimi; Seyyed Abbas Mirvakili; Mohammad Hossein Baradaranfar; Mohammad Hossein Dadgarnia
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-01-24       Impact factor: 2.503

8.  Randomized clinical trial to evaluate mometasone lavage vs spray for patients with chronic rhinosinusitis without nasal polyps who have not undergone sinus surgery.

Authors:  Pawina Jiramongkolchai; Andrew Peterson; Dorina Kallogjeri; Jake J Lee; Sara Kukuljan; Adam Liebendorfer; John S Schneider; Cristine N Klatt-Cromwell; Andrew J Drescher; Jay F Piccirillo
Journal:  Int Forum Allergy Rhinol       Date:  2020-05-29       Impact factor: 3.858

Review 9.  Different types of intranasal steroids for chronic rhinosinusitis.

Authors:  Lee Yee Chong; Karen Head; Claire Hopkins; Carl Philpott; Martin J Burton; Anne G M Schilder
Journal:  Cochrane Database Syst Rev       Date:  2016-04-26

10.  Long-term Results of Stellate Ganglion Block in Patients with Olfactory Dysfunction.

Authors:  Ho Sik Moon; Jin Young Chon; Sang Hoon Lee; Yu Mi Ju; Choon Ho Sung
Journal:  Korean J Pain       Date:  2013-01-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.